“Biotech is Broken!” “Pharmaceuticals Out of Balance!” “Venture Capital abandoning Biotech Sector!” Lately articles on the state of biotech scream out like spinning headlines on the MovieTone News Reels from seventy years ago: “Millions out of work!” or “War in the Pacific!” Since I’m penning my article on Pearl Harbor Day, the dramatic headlines pop … Continue reading “Chicken Little is History, Now It’s Time for Old School VC”
Author: Charlotte Hubbert
Charlotte Hubbert is an Associate and Kauffman Fellow with Accelerator Corporation, a Seattle-based privately-held biotechnology investment and development company that is building the next generation of biotechnology companies. She has twelve years of life sciences experience, with proven performance in internationally recognized publications including Science and Nature. Charlotte holds a Ph.D.from Duke University and recently finished post-doctoral training at the University of Washington Institute for Stem Cell and Regenerative Medicine. Prior to science, she was an impoverished musician and trouble-making rockstar.
From Academics to Biotech: A Journey to the Supposed “Dark Side”
If you had told me last year that today I would be running the offices of Accelerator Corporation—at least for one morning while everyone is out of town—I would have probably sniffed in disdain, tossed my hair, and shuffled back to my post-doc lab bench, a free donut in one hand (magic vendor food) and … Continue reading “From Academics to Biotech: A Journey to the Supposed “Dark Side””